Intra-Abdominal Infection Clinical Trials

11 recruitingLast updated: May 11, 2026

There are 11 actively recruiting intra-abdominal infection clinical trials across 5 countries. Studies span Phase 3, Not Applicable, Phase 1, Phase 2, Phase 4. Top locations include Shanghai, Shanghai Municipality, China, Hangzhou, Zhejiang, China, Aberystwyth, United Kingdom. Updated daily from ClinicalTrials.gov.


Intra-Abdominal Infection Trials at a Glance

11 actively recruiting trials for intra-abdominal infection are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 3 with 3 trials, with the heaviest enrollment activity in Shanghai, Hangzhou, and Aberystwyth. Lead sponsors running intra-abdominal infection studies include Central Hospital, Nancy, France, Shanghai Zhongshan Hospital, and Joincare Pharmaceutical Group Industry Co., Ltd.

Browse intra-abdominal infection trials by phase

Treatments under study

About Intra-Abdominal Infection Clinical Trials

Looking for clinical trials for Intra-Abdominal Infection? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Intra-Abdominal Infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Intra-Abdominal Infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 2

A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI)

Complicated Intra-abdominal Infections (cIAI)
Tetraphase Pharmaceuticals, Inc35 enrolled5 locationsNCT06794541
Recruiting
Not Applicable

The Effect of Continuous Intravenous Infusion of Lidocaine on PPCs and Prognosis in Emergency Surgical Patients With IAI

Intra-Abdominal InfectionPostoperative pulmonary complications
Shanghai Zhongshan Hospital428 enrolled1 locationNCT06304779
Recruiting

Rezafungin Peritoneal Diffusion for Intra-abdominal Candidiasis

abdominal surgery patientsCandidaCritically Ill Intensive Care Unit Patients+1 more
Central Hospital, Nancy, France20 enrolled1 locationNCT07093203
Recruiting

Real-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE

Ventilator-Associated Pneumonia (VAP)Hospital Acquired Pneumonia (HAP)Complicated Intra-Abdominal Infections, cIAIs
Sir Run Run Shaw Hospital100 enrolled2 locationsNCT07268560
Recruiting
Phase 4

Gelaspan vs Crystalloid Therapy in Sepsis

SepsisIntra-Abdominal Infections
Shanghai Zhongshan Hospital318 enrolled9 locationsNCT07172451
Recruiting

Innate Immune Response Monitoring Via Monocyte HLA-DR in Severe Intra-abdominal Infections at Risk of Fungal Infection

Critical IllnessIntra-Abdominal InfectionPost-Op Infection+2 more
Central Hospital, Nancy, France100 enrolled1 locationNCT07130799
Recruiting
Phase 1

Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers

Bacterial InfectionsRespiratory Tract InfectionsUrinary Tract Infections+1 more
Joincare Pharmaceutical Group Industry Co., Ltd66 enrolled1 locationNCT07207291
Recruiting

A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea

Hospital-Acquired PneumoniaComplicated urinary tract infectionComplicated Intra-abdominal Infection
Pfizer600 enrolled1 locationNCT05733104
Recruiting
Phase 3

Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections

Hospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP)Complicated Intra-abdominal Infection (cIAI)+2 more
Qilu Pharmaceutical Co., Ltd.80 enrolled1 locationNCT07089186
Recruiting
Phase 3

EXTENDed Antibiotic Durations Compared to Standard Durations for Patients With Complicated Intra-abdominal Infection.

Complicated Intra-abdominal Infection
Sarah Cockayne1,166 enrolled36 locationsNCT05148702
Recruiting
Phase 3

Study Comparing Caspofungin to Placebo for the Treatment of ICU Intra-abdominal Candidiasis

ICU Yeast Intra-abdominal Infection
Centre Hospitalier Universitaire, Amiens448 enrolled1 locationNCT03580733